Portrait de Julie Hussin

Julie Hussin

Membre académique associé
Professeure adjointe, Université de Montréal

Biographie

Julie Hussin est professeure agrégée à la Faculté de médecine de l'Université de Montréal (UdeM) et chercheuse à l'Institut de cardiologie de Montréal (ICM). Elle est aussi chercheuse-boursière junior 2 du Fonds de recherche du Québec - Santé (FRQS) et responsable des programmes d'études supérieures en bio-informatique à l'UdeM.

Julie Hussin a été formée en génomique statistique et évolutive et possède une vaste expérience dans l'analyse de données multi-omiques issues de vastes cohortes populationnelles. Ses travaux en biologie computationnelle se concentrent principalement sur la génomique médicale et des populations, contribuant à plusieurs avancées méthodologiques dans ces domaines. Son travail interdisciplinaire vise à développer des outils novateurs pour la médecine de précision.

Ses projets de recherche se focalisent sur l'amélioration de la prédiction de risques et la gestion des maladies cardiométaboliques, en particulier dans le cas de l'insuffisance cardiaque. Les méthodologies utilisées dans son groupe intègrent différentes sources de données, notamment des données cliniques, génétiques, transcriptomiques, protéomiques et métabolomiques, pour permettre la découverte de nouvelles informations sur les déterminants biologiques des maladies cardiaques, notamment par des techniques d’apprentissage non supervisé. Dans le contexte de la pandémie de COVID-19, son équipe a également développé des approches d’analyse de données génétiques des virus, pour la surveillance virale et l’étude des interactions hôte-pathogène ainsi que l'évolution virale.

Ses intérêts de recherche comprennent également l'interprétabilité, la généralisation et l'équité des algorithmes d'apprentissage automatique dans la recherche en santé. Julie Hussin s'engage à promouvoir activement une IA équitable, sûre et transparente dans la recherche en santé et s'efforce d'assurer l'inclusivité et la représentativité des individus dans sa recherche, pour que son travail bénéficie à l'ensemble de la population. Elle partage son expertise en donnant plusieurs cours de bio-informatique et de génétique des populations, ainsi que d’apprentissage automatique en génomique. Avant de se joindre à l'Université de Montréal en tant que professeure, elle a été boursière postdoctorale du Human Frontier Science Program au Wellcome Trust Centre for Human Genetics de l'Université d'Oxford (Linacre College) et chercheuse postdoctorale invitée à l'Université McGill.

Étudiants actuels

Doctorat - Université de Montréal
Doctorat - Université de Montréal
Co-superviseur⋅e :
Doctorat - Université de Montréal
Doctorat - Université de Montréal
Doctorat - Université de Montréal
Doctorat - Université de Montréal
Co-superviseur⋅e :
Maîtrise recherche - Université de Montréal

Publications

Intra-Host Evolution Analyses in an Immunosuppressed Patient Supports SARS-CoV-2 Viral Reservoir Hypothesis
Dominique Fournelle
Fatima Mostefai
Elsa Brunet-Ratnasingham
Raphael Poujol
Jean-Christophe Grenier
José Héctor Gálvez
Amélie Pagliuzza
Inès Levade
Sandrine Moreira
Mehdi Benlarbi
Guillaume Beaudoin-Bussières
Gabrielle Gendron-Lepage
Catherine Bourassa
Alexandra Tauzin
Simon Grandjean Lapierre
Nicolas Chomont
Andrés Finzi
Daniel E. Kaufmann
Morgan Craig
Temperature-dependent Spike-ACE2 interaction of Omicron subvariants is associated with viral transmission
Mehdi Benlarbi
Shilei Ding
Étienne Bélanger
Alexandra Tauzin
Raphael Poujol
Halima Medjahed
Omar El Ferri
Yuxia Bo
Catherine Bourassa
Judith Fafard
Marzena Pazgier
Inès Levade
Cameron Abrams
Marceline Côté
Andrés Finzi
The continued evolution of SARS-CoV-2 requires persistent monitoring of its subvariants. Omicron subvariants are responsible for the vast ma… (voir plus)jority of SARS-CoV-2 infections worldwide, with XBB and BA.2.86 sublineages representing more than 90% of circulating strains as of January 2024. In this study, we characterized the functional properties of Spike glycoproteins from BA.2.75, CH.1.1, DV.7.1, BA.4/5, BQ.1.1, XBB, XBB.1, XBB.1.16, XBB.1.5, FD.1.1, EG.5.1, HK.3 BA.2.86 and JN.1. We tested their capacity to evade plasma-mediated recognition and neutralization, ACE2 binding, their susceptibility to cold inactivation, Spike processing, as well as the impact of temperature on Spike-ACE2 interaction. We found that compared to the early wild-type (D614G) strain, most Omicron subvariants Spike glycoproteins evolved to escape recognition and neutralization by plasma from individuals who received a fifth dose of bivalent (BA.1 or BA.4/5) mRNA vaccine and improve ACE2 binding, particularly at low temperatures. Moreover, BA.2.86 had the best affinity for ACE2 at all temperatures tested. We found that Omicron subvariants Spike processing is associated with their susceptibility to cold inactivation. Intriguingly, we found that Spike-ACE2 binding at low temperature was significantly associated with growth rates of Omicron subvariants in humans. Overall, we report that Spikes from newly emerged Omicron subvariants are relatively more stable and resistant to plasma-mediated neutralization, present improved affinity for ACE2 which is associated, particularly at low temperatures, with their growth rates.
Genetic landscape of an in vivo protein interactome
Savandara Besse
Tatsuya Sakaguchi
Louis Gauthier
Zahra Sahaf
Olivier Péloquin
Lidice Gonzalez
Xavier Castellanos-Girouard
Nazli Koçatug
Chloé Matta
Stephen W. Michnick
Adrian W.R. Serohijos
Gene-metabolite annotation with shortest reactional distance enhances metabolite genome-wide association studies results
Cantin Baron
Sarah Cherkaoui
Sandra Therrien-Laperriere
Yann Ilboudo
Raphael Poujol
Pamela Mehanna
Melanie E. Garrett
Marilyn J. Telen
Allison E. Ashley-Koch
Pablo Bartolucci
John D. Rioux
Guillaume Lettre
Christine Des Rosiers
Matthieu Ruiz
Studies combining metabolomics and genetics, known as metabolite genome-wide association studies (mGWAS), have provided valuable insights in… (voir plus)to our understanding of the genetic control of metabolite levels. However, the biological interpretation of these associations remains challenging due to a lack of existing tools to annotate mGWAS gene-metabolite pairs beyond the use of conservative statistical significance threshold. Here, we computed the shortest reactional distance (SRD) based on the curated knowledge of the KEGG database to explore its utility in enhancing the biological interpretation of results from three independent mGWAS, including a case study on sickle cell disease patients. Results show that, in reported mGWAS pairs, there is an excess of small SRD values and that SRD values and p-values significantly correlate, even beyond the standard conservative thresholds. The added-value of SRD annotation is shown for identification of potential false negative hits, exemplified by the finding of gene-metabolite associations with SRD ≤1 that did not reach standard genome-wide significance cut-off. The wider use of this statistic as an mGWAS annotation would prevent the exclusion of biologically relevant associations and can also identify errors or gaps in current metabolic pathway databases. Our findings highlight the SRD metric as an objective, quantitative and easy-to-compute annotation for gene-metabolite pairs that can be used to integrate statistical evidence to biological networks.
Toward computing attributions for dimensionality reduction techniques
Matthew Scicluna
Jean-Christophe Grenier
Raphael Poujol
Multiscale PHATE identifies multimodal signatures of COVID-19
Manik Kuchroo
Je-chun Huang
Patrick W. Wong
Jean-Christophe Grenier
Dennis L. Shung
Alexander Tong
C. Lucas
J. Klein
Daniel B. Burkhardt
Scott Gigante
Abhinav Godavarthi
Bastian Rieck
Benjamin Israelow
Michael Simonov
Tianyang Mao
Ji Eun Oh
Julio Silva
Takehiro Takahashi
C. Odio
Arnau Casanovas‐massana … (voir 10 de plus)
John Byrne Fournier
Shelli F. Farhadian
C. D. Dela Cruz
A. Ko
Matthew Hirn
F. Wilson
Akiko Iwasaki
Smita Krishnaswamy
Multiscale PHATE identifies multimodal signatures of COVID-19
Manik Kuchroo
Je-chun Huang
Patrick Wong
Jean-Christophe Grenier
Dennis Shung
Alexander Tong
Carolina Lucas
Jon Klein
Daniel B. Burkhardt
Scott Gigante
Abhinav Godavarthi
Bastian Rieck
Benjamin Israelow
Michael Simonov
Tianyang Mao
Ji Eun Oh
Julio Silva
Takehiro Takahashi
Camila D. Odio
Arnau Casanovas-Massana … (voir 10 de plus)
John Fournier
Shelli Farhadian
Charles S. Dela Cruz
Albert I. Ko
Matthew Hirn
F. Perry Wilson
Akiko Iwasaki
Smita Krishnaswamy
Population Genomics Approaches for Genetic Characterization of SARS-CoV-2 Lineages
Fatima Mostefai
Isabel Gamache
Arnaud N’Guessan
Justin Pelletier
Jessie Huang
Carmen Lia Murall
Ahmad Pesaranghader
Vanda Gaonac'h-Lovejoy
David J. Hamelin
Raphael Poujol
Jean-Christophe Grenier
Martin Smith
Etienne Caron
Morgan Craig
Smita Krishnaswamy
B. Jesse Shapiro
Population Genomics Approaches for Genetic Characterization of SARS-CoV-2 Lineages
Fatima Mostefai
I. Gamache
Arnaud N’Guessan
Justin Pelletier
Jessie Huang
Carmen Lia Murall
Ahmad Pesaranghader
Vanda Gaonac'h-Lovejoy
David J. Hamelin
Raphael Poujol
Jean-Christophe Grenier
Martin W. Smith
Étienne Caron
Morgan Craig
Smita Krishnaswamy
B. Jesse Shapiro
The genome of the Severe Acute Respiratory Syndrome coronavirus 2 (SARS-CoV-2), the pathogen that causes coronavirus disease 2019 (COVID-19)… (voir plus), has been sequenced at an unprecedented scale leading to a tremendous amount of viral genome sequencing data. To assist in tracing infection pathways and design preventive strategies, a deep understanding of the viral genetic diversity landscape is needed. We present here a set of genomic surveillance tools from population genetics which can be used to better understand the evolution of this virus in humans. To illustrate the utility of this toolbox, we detail an in depth analysis of the genetic diversity of SARS-CoV-2 in first year of the COVID-19 pandemic. We analyzed 329,854 high-quality consensus sequences published in the GISAID database during the pre-vaccination phase. We demonstrate that, compared to standard phylogenetic approaches, haplotype networks can be computed efficiently on much larger datasets. This approach enables real-time lineage identification, a clear description of the relationship between variants of concern, and efficient detection of recurrent mutations. Furthermore, time series change of Tajima's D by haplotype provides a powerful metric of lineage expansion. Finally, principal component analysis (PCA) highlights key steps in variant emergence and facilitates the visualization of genomic variation in the context of SARS-CoV-2 diversity. The computational framework presented here is simple to implement and insightful for real-time genomic surveillance of SARS-CoV-2 and could be applied to any pathogen that threatens the health of populations of humans and other organisms.